Zenome Breaking News Newly Formed Advocacy Group Urges FDA Action on Alzheimer's Disease Risk Gene FDA Approves Abeona's Zevaskyn, EC Authorizes Krystal's Vyjuvek for Rare Skin Disease Octave Bioscience Gets NY State Certification for MS Test Merck KGaA Buying SpringWorks Therapeutics to Strengthen US Presence in Rare Tumors EntroGen Colorectal Cancer RAS Mutation Detection Test Nabs CMS Coverage BlackfinBio Launching Gene Therapy Trial in Rare Neurological Condition at Boston Children's
